AbbVie has filed for approval of a regimen based on its Venclexta therapy for previously untreated patients with chronic lymphocytic leukaemia (CLL), in combination with an AstraZeneca drug. The ...

Good Saturday morning, everyone. After a mild Halloween to wrap up the month yesterday, November is off to a cooler start thanks to clouds and some light areas of sprinkles and rain this morning. This ...